Αμφοτερικίνη Β (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Αμφοτερικίνη Β" in Greek language version.

refsWebsite

Global rank Greek rank

20nih.gov

4^th place

16doi.org

2^nd place

3^rd place

10worldcat.org

5^th place

8^th place

3web.archive.org

1^st place

2archive.org

6^th place

5^th place

2books.google.com

3^rd place

6^th place

1drugs.com

399^th place

130^th place

1mit.edu

415^th place

412^th place

1thefreedictionary.com

614^th place

445^th place

1uwec.edu

low place

archive.org

WHO Model Formulary 2008. World Health Organization. 2009. σελ. 145. ISBN 9789241547659.
Bennett, John (2000-11-15). «Editorial Response: Choosing Amphotericin B Formulations—Between a Rock and a Hard Place» (στα αγγλικά). Clinical Infectious Diseases 31 (5): 1164–1165. doi:10.1086/317443. ISSN 1058-4838. PMID 11073746. https://archive.org/details/sim_clinical-infectious-diseases_2000-11_31_5/page/1164.

books.google.com

Walker, S. R. (2012). Trends and Changes in Drug Research and Development (στα Αγγλικά). Springer Science & Business Media. σελ. 109. ISBN 9789400926592.
Fischer, Jnos· Ganellin, C. Robin (2006). Analogue-based Drug Discovery (στα Αγγλικά). John Wiley & Sons. σελ. 477. ISBN 9783527607495.

doi.org

dx.doi.org

Moen, Marit D.; Lyseng-Williamson, Katherine A.; Scott, Lesley J. (2012-09-17). «Liposomal Amphotericin B». Drugs 69 (3): 361–392. doi:10.2165/00003495-200969030-00010. ISSN 0012-6667. PMID 19275278.
den Boer, Margriet; Davidson, Robert N. (2006-04-01). «Treatment options for visceral leishmaniasis». Expert Review of Anti-Infective Therapy 4 (2): 187–197. doi:10.1586/14787210.4.2.187. ISSN 1744-8336. PMID 16597201.
Grace, Eddie; Asbill, Scott; Virga, Kris (November 2015). «Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options». Antimicrobial Agents and Chemotherapy 59 (11): 6677–6681. doi:10.1128/AAC.01293-15. PMID 26259797.
Dutcher, James D. (1968-10-01). «THe discovery and development of amphotericin b». Chest 54 (Supplement_1): 296–298. doi:10.1378/chest.54.Supplement_1.296. ISSN 0012-3692. PMID 4877964.
Hamill, Richard J. (2013-06-01). «Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity». Drugs 73 (9): 919–934. doi:10.1007/s40265-013-0069-4. ISSN 0012-6667. PMID 23729001.
Botero Aguirre, Juan Pablo; Restrepo Hamid, Alejandra Maria (2015-11-23). «Amphotericin B deoxycholate versus liposomal amphotericin B: Effects on kidney function» (στα αγγλικά). Cochrane Database of Systematic Reviews (11): CD010481. doi:10.1002/14651858.cd010481.pub2. PMID 26595825.
Mistro, Sóstenes; Maciel, Isis de M.; Menezes, Rouseli G. de; Maia, Zuinara P.; Schooley, Robert T.; Badaró, Roberto (2012-06-15). «Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis». Clinical Infectious Diseases 54 (12): 1774–1777. doi:10.1093/cid/cis290. ISSN 1058-4838. PMID 22491505.
Bennett, John (2000-11-15). «Editorial Response: Choosing Amphotericin B Formulations—Between a Rock and a Hard Place» (στα αγγλικά). Clinical Infectious Diseases 31 (5): 1164–1165. doi:10.1086/317443. ISSN 1058-4838. PMID 11073746. https://archive.org/details/sim_clinical-infectious-diseases_2000-11_31_5/page/1164.
«Highly Effective oral amphotericin B formulation against murine visceral leishmaniasis». J Infect Dis 200 (3): 357–360. 2009. doi:10.1086/600105. PMID 19545212.
Pappas, Peter G.; Kauffman, Carol A.; Andes, David; Benjamin, Daniel K.; Calandra, Thierry F.; Edwards, John E.; Filler, Scott G.; Fisher, John F. και άλλοι. (2009-03-01). «Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America». Clinical Infectious Diseases 48 (5): 503–535. doi:10.1086/596757. ISSN 1537-6591. PMID 19191635.
Walsh, Thomas J.; Finberg, Robert W.; Arndt, Carola; Hiemenz, John; Schwartz, Cindy; Bodensteiner, David; Pappas, Peter; Seibel, Nita και άλλοι. (1999-03-11). «Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia». New England Journal of Medicine 340 (10): 764–771. doi:10.1056/NEJM199903113401004. ISSN 0028-4793. PMID 10072411.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A. και άλλοι. (2010-02-01). «Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America». Clinical Infectious Diseases 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMID 20047480.
Zietse, R.; Zoutendijk, R.; Hoorn, E. J. (2009). «Fluid, electrolyte and acid–base disorders associated with antibiotic therapy». Nature Reviews Nephrology 5 (4): 193–202. doi:10.1038/nrneph.2009.17. PMID 19322184.
Mesa-Arango, Ana Cecilia; Scorzoni, Liliana; Zaragoza, Oscar (2012-01-01). «It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug». Frontiers in Microbiology 3: 286. doi:10.3389/fmicb.2012.00286. PMID 23024638.
O'Keeffe, Joseph; Doyle, Sean; Kavanagh, Kevin (2003-12-01). «Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B». Journal of Pharmacy and Pharmacology 55 (12): 1629–1633. doi:10.1211/0022357022359. ISSN 2042-7158. PMID 14738588.
Baginski, M.; Czub, J. (2009). «Amphotericin B and Its New Derivatives–Mode of Action». Current Drug Metabolism 10 (5): 459–69. doi:10.2174/138920009788898019. PMID 19689243.

drugs.com

«Amphotericin B». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Ιανουαρίου 2015. Ανακτήθηκε στις 1 Ιανουαρίου 2015.

mit.edu

wi.mit.edu

Rura, Nicole (2013-10-29). «Understanding the evolution of drug resistance points to novel strategy for developing better antimicrobials». Αρχειοθετήθηκε από το πρωτότυπο στις 2016-11-15. https://web.archive.org/web/20161115134239/http://wi.mit.edu/news/archive/2013/understanding-evolution-drug-resistance-points-novel-strategy-developing-better. Ανακτήθηκε στις 2016-11-14.

nih.gov

ncbi.nlm.nih.gov

Moen, Marit D.; Lyseng-Williamson, Katherine A.; Scott, Lesley J. (2012-09-17). «Liposomal Amphotericin B». Drugs 69 (3): 361–392. doi:10.2165/00003495-200969030-00010. ISSN 0012-6667. PMID 19275278.
den Boer, Margriet; Davidson, Robert N. (2006-04-01). «Treatment options for visceral leishmaniasis». Expert Review of Anti-Infective Therapy 4 (2): 187–197. doi:10.1586/14787210.4.2.187. ISSN 1744-8336. PMID 16597201.
Grace, Eddie; Asbill, Scott; Virga, Kris (November 2015). «Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options». Antimicrobial Agents and Chemotherapy 59 (11): 6677–6681. doi:10.1128/AAC.01293-15. PMID 26259797.
Dutcher, James D. (1968-10-01). «THe discovery and development of amphotericin b». Chest 54 (Supplement_1): 296–298. doi:10.1378/chest.54.Supplement_1.296. ISSN 0012-3692. PMID 4877964.
Hamill, Richard J. (2013-06-01). «Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity». Drugs 73 (9): 919–934. doi:10.1007/s40265-013-0069-4. ISSN 0012-6667. PMID 23729001.
Botero Aguirre, Juan Pablo; Restrepo Hamid, Alejandra Maria (2015-11-23). «Amphotericin B deoxycholate versus liposomal amphotericin B: Effects on kidney function» (στα αγγλικά). Cochrane Database of Systematic Reviews (11): CD010481. doi:10.1002/14651858.cd010481.pub2. PMID 26595825.
Mistro, Sóstenes; Maciel, Isis de M.; Menezes, Rouseli G. de; Maia, Zuinara P.; Schooley, Robert T.; Badaró, Roberto (2012-06-15). «Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis». Clinical Infectious Diseases 54 (12): 1774–1777. doi:10.1093/cid/cis290. ISSN 1058-4838. PMID 22491505.
Bennett, John (2000-11-15). «Editorial Response: Choosing Amphotericin B Formulations—Between a Rock and a Hard Place» (στα αγγλικά). Clinical Infectious Diseases 31 (5): 1164–1165. doi:10.1086/317443. ISSN 1058-4838. PMID 11073746. https://archive.org/details/sim_clinical-infectious-diseases_2000-11_31_5/page/1164.
«Highly Effective oral amphotericin B formulation against murine visceral leishmaniasis». J Infect Dis 200 (3): 357–360. 2009. doi:10.1086/600105. PMID 19545212.
Pappas, Peter G.; Kauffman, Carol A.; Andes, David; Benjamin, Daniel K.; Calandra, Thierry F.; Edwards, John E.; Filler, Scott G.; Fisher, John F. και άλλοι. (2009-03-01). «Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America». Clinical Infectious Diseases 48 (5): 503–535. doi:10.1086/596757. ISSN 1537-6591. PMID 19191635.
Walsh, Thomas J.; Finberg, Robert W.; Arndt, Carola; Hiemenz, John; Schwartz, Cindy; Bodensteiner, David; Pappas, Peter; Seibel, Nita και άλλοι. (1999-03-11). «Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia». New England Journal of Medicine 340 (10): 764–771. doi:10.1056/NEJM199903113401004. ISSN 0028-4793. PMID 10072411.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A. και άλλοι. (2010-02-01). «Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America». Clinical Infectious Diseases 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMID 20047480.
Zietse, R.; Zoutendijk, R.; Hoorn, E. J. (2009). «Fluid, electrolyte and acid–base disorders associated with antibiotic therapy». Nature Reviews Nephrology 5 (4): 193–202. doi:10.1038/nrneph.2009.17. PMID 19322184.
Mesa-Arango, Ana Cecilia; Scorzoni, Liliana; Zaragoza, Oscar (2012-01-01). «It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug». Frontiers in Microbiology 3: 286. doi:10.3389/fmicb.2012.00286. PMID 23024638.
O'Keeffe, Joseph; Doyle, Sean; Kavanagh, Kevin (2003-12-01). «Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B». Journal of Pharmacy and Pharmacology 55 (12): 1629–1633. doi:10.1211/0022357022359. ISSN 2042-7158. PMID 14738588.
Baginski, M.; Czub, J. (2009). «Amphotericin B and Its New Derivatives–Mode of Action». Current Drug Metabolism 10 (5): 459–69. doi:10.2174/138920009788898019. PMID 19689243.

pubmedcentral.nih.gov

Grace, Eddie; Asbill, Scott; Virga, Kris (November 2015). «Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options». Antimicrobial Agents and Chemotherapy 59 (11): 6677–6681. doi:10.1128/AAC.01293-15. PMID 26259797.
Pappas, Peter G.; Kauffman, Carol A.; Andes, David; Benjamin, Daniel K.; Calandra, Thierry F.; Edwards, John E.; Filler, Scott G.; Fisher, John F. και άλλοι. (2009-03-01). «Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America». Clinical Infectious Diseases 48 (5): 503–535. doi:10.1086/596757. ISSN 1537-6591. PMID 19191635.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A. και άλλοι. (2010-02-01). «Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America». Clinical Infectious Diseases 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMID 20047480.
Mesa-Arango, Ana Cecilia; Scorzoni, Liliana; Zaragoza, Oscar (2012-01-01). «It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug». Frontiers in Microbiology 3: 286. doi:10.3389/fmicb.2012.00286. PMID 23024638.

thefreedictionary.com

medical-dictionary.thefreedictionary.com

«Shake and Bake». TheFreeDictionary.com. http://medical-dictionary.thefreedictionary.com/Shake+and+Bake. Ανακτήθηκε στις 2016-12-09.

uwec.edu

chem.uwec.edu

Hartsel, Scott. «Studies on Amphotericin B» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 20 Δεκεμβρίου 2016. Ανακτήθηκε στις 8 Δεκεμβρίου 2016.

web.archive.org

«Amphotericin B». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Ιανουαρίου 2015. Ανακτήθηκε στις 1 Ιανουαρίου 2015.
Rura, Nicole (2013-10-29). «Understanding the evolution of drug resistance points to novel strategy for developing better antimicrobials». Αρχειοθετήθηκε από το πρωτότυπο στις 2016-11-15. https://web.archive.org/web/20161115134239/http://wi.mit.edu/news/archive/2013/understanding-evolution-drug-resistance-points-novel-strategy-developing-better. Ανακτήθηκε στις 2016-11-14.
Hartsel, Scott. «Studies on Amphotericin B» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 20 Δεκεμβρίου 2016. Ανακτήθηκε στις 8 Δεκεμβρίου 2016.

worldcat.org

Moen, Marit D.; Lyseng-Williamson, Katherine A.; Scott, Lesley J. (2012-09-17). «Liposomal Amphotericin B». Drugs 69 (3): 361–392. doi:10.2165/00003495-200969030-00010. ISSN 0012-6667. PMID 19275278.
den Boer, Margriet; Davidson, Robert N. (2006-04-01). «Treatment options for visceral leishmaniasis». Expert Review of Anti-Infective Therapy 4 (2): 187–197. doi:10.1586/14787210.4.2.187. ISSN 1744-8336. PMID 16597201.
Dutcher, James D. (1968-10-01). «THe discovery and development of amphotericin b». Chest 54 (Supplement_1): 296–298. doi:10.1378/chest.54.Supplement_1.296. ISSN 0012-3692. PMID 4877964.
Hamill, Richard J. (2013-06-01). «Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity». Drugs 73 (9): 919–934. doi:10.1007/s40265-013-0069-4. ISSN 0012-6667. PMID 23729001.
Mistro, Sóstenes; Maciel, Isis de M.; Menezes, Rouseli G. de; Maia, Zuinara P.; Schooley, Robert T.; Badaró, Roberto (2012-06-15). «Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis». Clinical Infectious Diseases 54 (12): 1774–1777. doi:10.1093/cid/cis290. ISSN 1058-4838. PMID 22491505.
Bennett, John (2000-11-15). «Editorial Response: Choosing Amphotericin B Formulations—Between a Rock and a Hard Place» (στα αγγλικά). Clinical Infectious Diseases 31 (5): 1164–1165. doi:10.1086/317443. ISSN 1058-4838. PMID 11073746. https://archive.org/details/sim_clinical-infectious-diseases_2000-11_31_5/page/1164.
Pappas, Peter G.; Kauffman, Carol A.; Andes, David; Benjamin, Daniel K.; Calandra, Thierry F.; Edwards, John E.; Filler, Scott G.; Fisher, John F. και άλλοι. (2009-03-01). «Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America». Clinical Infectious Diseases 48 (5): 503–535. doi:10.1086/596757. ISSN 1537-6591. PMID 19191635.
Walsh, Thomas J.; Finberg, Robert W.; Arndt, Carola; Hiemenz, John; Schwartz, Cindy; Bodensteiner, David; Pappas, Peter; Seibel, Nita και άλλοι. (1999-03-11). «Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia». New England Journal of Medicine 340 (10): 764–771. doi:10.1056/NEJM199903113401004. ISSN 0028-4793. PMID 10072411.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A. και άλλοι. (2010-02-01). «Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America». Clinical Infectious Diseases 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMID 20047480.
O'Keeffe, Joseph; Doyle, Sean; Kavanagh, Kevin (2003-12-01). «Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B». Journal of Pharmacy and Pharmacology 55 (12): 1629–1633. doi:10.1211/0022357022359. ISSN 2042-7158. PMID 14738588.